WHWK
Whitehawk Therapeutics Inc.

6,503
Loading...
Loading...
News
all
press releases
News Placeholder
Tempus AI Fuels Growth Through Strategic Biotech Collaborations
TEM expands its AI-driven growth with new collaborations in oncology, neurogenomics, and diagnostic innovation.
Zacks·2d ago
News Placeholder
Whitehawk Therapeutics Stock Rallies 25% On Tempus AI Collaboration Deal: Retail Hopes For A Rally Toward $5 Mark
Under the deal, Whitehawk Therapeutics will apply Tempus’ real-world dataset, including, de-identified multimodal database, to support its clinical trial designs.
Stocktwits·3d ago
News Placeholder
Tempus Announces Collaboration with Whitehawk Therapeutics to Advance Biomarker-Driven Oncology Research
Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced a multi-year collaboration with Whitehawk Therapeutics, Inc. (NASDAQ...
Business Wire·3d ago
News Placeholder
Implied Volatility Surging for Whitehawk Therapeutics Stock Options
Zacks·4mo ago

Latest WHWK News

View

Advertisement|Remove ads.

Advertisement|Remove ads.